After market close Thursday, Hims & Hers disclosed in a regulatory filing that COO Nader Kabbani had vacated his position.

Hims & Hers Health, Inc. (HIMS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want ...

Today, Benzinga 's options scanner spotted 32 uncommon options trades for Hims & Hers Health. This isn't normal. The overall ...

Get the latest analysis on Hims & Hers Health, Inc. stock with valuation insights, business risks, and forecasts. Click here ...

Hims & Hers Health (HIMS) has seen its stock climb steadily, jumping 39% in the past month. This upward trend is catching attention, with investors curious about what is fueling the company’s ongoing ...

Hims & Hers Health, Inc. stock may offer more upside amid digital health growth, despite FDA scrutiny and tariff risks. Click ...

Hims stock is near a buy point of 60.55 in a cup-with-handle base. The IBD 50 growth stock has gained 126% year-to-date.

Hims & Hers is promoting Chief Commercial Officer Mike Chi to operating chief. Chi will succeed Nader Kabbani as chief operating officer on Nov. 2, the digital healthcare company said. Kabbani plans ...

YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs ...

More than 40% of American adults live with obesity, yet personalized, supportive care is often out of reach due to challenges ...